facebook_pixel

@Pfizer

News 31 March 2019
BLUE PHOENIX FINANCIALS PREMIUM CONTENT Not a member? Join Now!
Big Pharma: How To Make 25% Using Interbank Equity Options

Big Pharma: How To Make 25% Using Interbank Equity Options

  Credit Suisse argues that there is plenty of upside in Pfizer’s pipeline   The back story. Pfizer was the second-best performing stock in the Dow Jones Industrial Average in 2018, behind fellow pharma giant Merck (MRK). It wasn’t all smooth sailing, because of concerns about potential drug price regulation. Still, overall the company benefited […]

FIND OUT MORE